How To Manage The Ebola Scare and A Worst Case Scenario Using Vitamin C


Some alternative health sites are pushing the Ebola scare as much as or even more so than the mainstream media, with many of their sources being mainstream. But the scare isn’t quite as intense as purported, at least not for us in America.

Let’s get to the basics on prevention first. Those poor people in West Africa suffer from many illnesses due to malnutrition, contaminated drinking water, pollution from unregulated petroleum extractions, and outrageous chronic stress from constant war within. None of this is an issue in the United States – at least not nearly to the same degree as in places like West Africa.

All four normally healthy Westerners who contracted Ebola were treated easily and comfortably with even mainstream medical techniques that included nutrition. Huh? They had strong enough immune systems intact, their inner terrains were not seriously acidic, and they were not encumbered with scurvy, unlike the natives they were sent to assist.

According to Robert F. Cathcart III, MD, an orthomolecular physician who administers mega-dose IV vitamin C, the CDC and WHO field workers on location refuse to check blood levels of vitamin C among the diseased Africans. This would spoil their heroic intervention games that are sponsored by Big Pharma for control and high profits.

If they did check vitamin C levels, they would find most if not all are suffering from acute induced scurvy that would force them to abandon anti-viral chemical agents and intensely bolster those vitamin C levels. Dr. Cathcart states, “… all the hemorrhagic fevers are acute induced scurvy.” Yes, Ebola is a hemorrhagic fever.

Ignore Mainstream Medicine and Look to Vitamin C for Ebola and More

During the 1940s and ’50s, Dr. Frederick Robert Klenner treated many cases of pneumonia and polio with high dose injections of vitamin C. He took his case documents to a 1949 Atlantic City AMA conference and was ignored.

Dr. Klenner stated:

When proper amounts are used, it will destroy all virus organisms. Don’t expect control of a virus with 100 to 400 mg of C”. He added, “Some physicians would stand by and see their patient die rather than use ascorbic acid because in their finite minds it exists only as a vitamin.”

Since then, others began using mega-dose vitamin C therapies for various diseases, physical and mental, with great success. Those doctors formed tight knit communities known as Orthomolecular Medicine and Psychiatry.

As for Ebola, they all recommend using high dose vitamin C repeatedly, every hour or two to bowel tolerance limits if administering IV C is impractical for whatever reasons. Then there is liposomal vitamin C, where molecules are encapsulated in lipids to allow easier penetration into lipid (fat) cell walls.

Dr. Thomas Levy, a seasoned veteran of administering mega-dose IV C, believes that highly encapsulated liposomal vitamin C may exceed IV C therapy’s efficacy clinically by a factor of 10! He based this opinion on actual clinical cases.

For any serious viral infection, 5 grams of liposomol C daily for 10 days is recommended.


Ebola is probably the best known of a class of viruses known as hemorrhagic fever viruses. In fact, Ebola virus was initially recognized in 1976. Other less known but related viral syndromes include yellow fever, dengue hemorrhagic fever, Rift Valley fever, Crimean-Congo hemorrhagic fever, Kyasanur Forest disease, Omsk hemorrhagic fever, hemorrhagic fever with renal syndrome, Hantavirus pulmonary syndrome, Venezuelan hemorrhagic fever, Brazilian hemorrhagic fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Lassa fever. The Ebola virus infection, also known as African hemorrhagic fever, has the distinction of having the highest case-fatality rate of the viral infections noted above, ranging from 53% to 88%.

These viral hemorrhagic fever syndromes share certain clinical features. The Cecil Textbook of Medicine notes that these diseases are characterized by capillary fragility, which translates to easy bleeding, that can frequently lead to severe shock and death. These diseases also tend to consume and/or destroy the platelets, which play an integral role in blood clotting. The clinical presentation of these viral diseases is similar to scurvy, which is also characterized by capillary fragility and a tendency to bleed easily. Characteristic skin lesions develop, which are actually multiple tiny areas of bleeding into the skin that surround the hair follicles. some cases even include bleeding into already healed scars.

In the classic form of scurvy that evolves very slowly from the gradual depletion of vitamin C body stores, the immune system will be sufficiently compromised for infection to claim the patient’s life before the extensive hemorrhage that occurs after all vitamin C stores have been completely exhausted. Ebola virus and the other viral hemorrhagic fevers are much more likely to cause hemorrhaging before any other fatal infection has a chance to become established. This is because the virus so rapidly and totally metabolizes and consumes all available vitamin C in the bodies of the victims that an advanced stage of scurvy is literally produced after only a few days of the disease. 

The scurvy is so complete that the blood vessels generally cannot keep from hemorrhaging long enough to allow an infective complication to develop. Also, the viral hemorrhagic fevers typically only take hold and reach epidemic proportions in those populations that would already be expected to have low body stores of vitamin C, such as is found in many of the severely malnourished Africans. In such individuals, an infecting hemorrhagic virus will often wipe out any remaining vitamin C stores before the immune systems can get the upper hand and initiate recovery. When the vitamin C stores are rapidly depleted by large infecting doses of an aggressive virus, the immune system gets similarly depleted and compromised. However, this point is largely academic after hemorrhaging throughout the body has begun.

To date, no viral infection has been demonstrated to be resistant to the proper dosing of vitamin C as classically demonstrated by Klenner. However, not all viruses have been treated with Klenner-sized vitamin C doses, or at least the results have not been published. Ebola viral infection and the other acute viral hemorrhagic fevers appear to be diseases that fall into this category. Because of the seemingly exceptional ability of these viruses to rapidly deplete vitamin C stores, even larger doses of vitamin C would likely be required in order to effectively reverse and eventually cure infections caused by these viruses.

Cathcart (1981), who introduced the concept of bowel tolerance to vitamin C discussed earlier, hypothesized that Ebola and the other acute viral hemorrhagic fevers may well require 500,000 mg of vitamin C daily to reach bowel tolerance! Whether this estimate is accurate, it seems clear as evidenced by the scurvy-like clinical manifestations of these infections that vitamin C dosing must be vigorous and given in extremely high doses. If the disease seems to be winning, then even more vitamin C should be given until symptoms begin to lessen. Obviously, these are viral diseases that would absolutely require high doses of vitamin C intravenously as the initial therapy. The oral administration should begin simultaneously, but the intravenous route should not be abandoned until the clinical response is complete. Death occurs too quickly with the hemorrhagic fevers to be conservative when dosing the vitamin C. (from Vitamin C, Infectious Diseases, and Toxins:Curing the Incurable by Thomas E. Levy MD JD)


by Paul Fassa